Skip to main content
OpenTrials
Recruiting

NCT Number: NCT03488732

Valvular Heart Disease Registry

Patients undergoing transcatheter valvular interventions will be prospectively included into the present registry. Baseline, procedural and follow-up data will be collected and analyzed to adress various issues in the field of percutaneous valvular interventions.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Klinik für Innere Medizin I

München, Germany

Location status: Recruiting

Location contact

Jakob Ledwoch, Dr

CONTACT

[email protected]

+4941402350

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Severe valvular defect planned for valvular intervention

Exclusion criteria

  • No informed consent

Treatment and study plan

Transcatheter valvular repair or replacement

Device

Transcatheter valvular repair (predominantly MitraClip for mitral regurgitation) or replacement (predominantly transcatheter aortic valve implantation for aortic stenosis)

Primary outcomes

  1. All-cause mortality

    Time frame: 10 years

Secondary outcomes

  1. Cardiovascular mortality

    Time frame: 10 years

  2. NYHA status

    Time frame: 10 years

  3. Grade of mitral regurgitation

    Time frame: 10 years

Sponsors and collaborators

Lead sponsor

Technical University of Munich

Other

Registry information

Official study title

Valvular Heart Disease Registry - Observational Study of Percutaneous Valvular Interventions

Important dates

Study start
2015
Primary completion
2025
Study completion
2030
First posted
Apr 5, 2018
Registry last updated
Apr 10, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.